Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis

Parse Biosciences launches a fully integrated immune repertoire and whole transcriptome analysis workflow in its data analysis platform, Trailmaker.
Targeted Oncology

NCCN Update Supports MammaPrint to Guide Anthracycline Use in Breast Cancer

The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...
BioProcess International

Have We Finally Reached the End of In Vitro Testing? Positioning NGS in Your Biosafety Testing Strategy

Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...

Scientists transform enigmatic cell structures into devices for recording RNA activity

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...
ascopubs.org

Clinical utility of comprehensive transcriptome testing in advanced solid tumors.

Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the primary staging of non-small cell lung cancer (NSCLC). Application of an epigenomic-based classifier to identify cancer signal of origin on ...
The Scientist

How Multiomics Enables Integrated Biological Analysis

Since the advent of the Human Genome Project, scientists have expanded efforts to map complete biological datasets that encompass entire molecular families, such as DNA, RNA, proteins, and metabolites ...
Pharmabiz

Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis

Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis: Seattle Saturday, January 24, 2026, 15:00 Hrs [IST] Parse Biosciences, the leading provider ...